As of 2025-10-15, the Relative Valuation of Moderna Inc (MRNA) is (103.34) USD. This relative valuation is based on P/E multiples. With the latest stock price at 26.25 USD, the upside of Moderna Inc based on Relative Valuation is -493.7%.
The range of the Relative Valuation is (102.52) - (103.26) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 13.8x | 13.6x |
| Forward P/E multiples | 13.7x - 14.7x | 14.1x |
| Fair Price | (102.52) - (103.26) | (103.34) |
| Upside | -490.5% - -493.4% | -493.7% |
| Date | P/E |
| 2025-10-15 | -3.67 |
| 2025-10-14 | -3.52 |
| 2025-10-13 | -3.58 |
| 2025-10-10 | -3.60 |
| 2025-10-09 | -3.69 |
| 2025-10-08 | -3.74 |
| 2025-10-07 | -3.66 |
| 2025-10-06 | -3.69 |
| 2025-10-03 | -3.82 |
| 2025-10-02 | -3.80 |
| 2025-10-01 | -3.70 |
| 2025-09-30 | -3.46 |
| 2025-09-29 | -3.39 |
| 2025-09-26 | -3.28 |
| 2025-09-25 | -3.30 |
| 2025-09-24 | -3.47 |
| 2025-09-23 | -3.46 |
| 2025-09-22 | -3.56 |
| 2025-09-19 | -3.38 |
| 2025-09-18 | -3.41 |
| 2025-09-17 | -3.35 |
| 2025-09-16 | -3.33 |
| 2025-09-15 | -3.20 |
| 2025-09-12 | -3.15 |
| 2025-09-11 | -3.40 |
| 2025-09-10 | -3.26 |
| 2025-09-09 | -3.28 |
| 2025-09-08 | -3.33 |
| 2025-09-05 | -3.37 |
| 2025-09-04 | -3.25 |
| 2025-09-03 | -3.22 |
| 2025-09-02 | -3.24 |
| 2025-08-29 | -3.23 |
| 2025-08-28 | -3.28 |
| 2025-08-27 | -3.36 |
| 2025-08-26 | -3.31 |
| 2025-08-25 | -3.40 |
| 2025-08-22 | -3.63 |
| 2025-08-21 | -3.51 |
| 2025-08-20 | -3.60 |
| 2025-08-19 | -3.74 |
| 2025-08-18 | -3.76 |
| 2025-08-15 | -3.76 |
| 2025-08-14 | -3.58 |
| 2025-08-13 | -3.60 |
| 2025-08-12 | -3.44 |
| 2025-08-11 | -3.41 |
| 2025-08-08 | -3.50 |
| 2025-08-07 | -3.57 |
| 2025-08-06 | -3.58 |